PubPeer
The online Journal club
login
create account
Home
Publications
US Food and Drug Administration embraces using innovation to identify optimized dosages for patients with cancer
CPT Pharmacometrics & Systems Pharmacology (2023) -
Comment
doi: 10.1002/psp4.13033 issn: 2163-8306 pubmed: 37641498
Stacy S. Shord, Hao Zhu, Jiang Liu, Atiqur Rahman, Brian Booth, Issam Zineh
Go to article
Go to preprint
Wiley
Comments awaiting moderation ({{totalComments}})
Review last reports ({{totalReports}})
Review last email suggestions ({{totalPendingEmails}})
Last month's whitelisted comments ({{totalWhitelistedComments}})